Learn More
Invitrogen™ cIAP2 Polyclonal Antibody

Description
Suggested positive control: Hela whole cell lysate; Jurkat whole cell lysate.
Specifications
Specifications
| Antigen | cIAP2 |
| Applications | Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 1.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 30% glycerol and 0.1% sodium azide |
| Gene | BIRC3 |
| Gene Accession No. | Q13489 |
| Gene Alias | AIP 2; AIP1; Api1; Api2; apoptosis inhibitor 1; apoptosis inhibitor 2; AW107670; baculoviral IAP repeat containing 3; baculoviral IAP repeat-containing 2; baculoviral IAP repeat-containing 3; baculoviral IAP repeat-containing protein 3; Birc2; Birc3; Cellular inhibitor of apoptosis 2; cIAP1; cIAP-1; cIAP2; C-IAP2; cIAP-2; H HIAP1; H MALT2; HAIP1; HIAP1; hIAP-1; HIAP2; IAP homolog; IAP homolog C; IAP1; IAP-1; IAP2; Inhibitor of apoptosis protein 1; MALT2; mammalian IAP homolog C; MIAP1; mIAP-1; MIAP2; MIHB; MIHC; RING finger protein 49; RING-type E3 ubiquitin transferase BIRC3; RNF49; TNFR2-TRAF signaling complex protein; TNFR2-TRAF-signaling complex protein 1 |
| Gene Symbols | BIRC3 |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.